Quest Diagnostics (DGX) Reports In-Line Q2 EPS; Trims FY12 Revs Growth Outlook

Go back to Quest Diagnostics (DGX) Reports In-Line Q2 EPS; Trims FY12 Revs Growth Outlook
Quest Diagnostics (NYSE: DGX) Delayed: 237.15 -0.62 (0.26%)
Previous Close $237.77    52 Week High $86.85 
Open $239.10    52 Week Low $59.66 
Day High $240.00    P/E 44.66 
Day Low $236.61    EPS $5.31 
Volume 119,502